A Henry Ford Health System study citing progress treating patients with the anti-malaria drug hydroxychloroquine is flawed, and should not be seen as evidence the drug is effective, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease, told a House hearing on investigating the federal government effort to control the pandemic.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts